Funder
Boehringer Ingelheim Pharmaceuticals, Inc.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference28 articles.
1. American Urological Association Guideline. Management of benign prostatic hyperplasia (BPH). American Urological Association Education and Research, Inc. 2010.
https://www.auanet.org/guidelines/benign-prostatic-hyperplasia-(2010-reviewed-and-validity-confirmed-2014
). Accessed 21 June 2017.
2. Flomax prescribing information.
http://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Flomax%20Caps/Flomax.pdf
. Accessed 21 June 2017.
3. Campschroer T, Zhu Y, Duijvesz D, Grobbee DE, Lock MT. Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst Rev. 2014;(4):CD008509.
https://doi.org/10.1002/14651858.cd008509.pub2
.
4. Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, et al. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016;2:16031.
https://doi.org/10.1038/nrdp.2016.31
.
5. Schulman CC. Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Expert Opin Drug Metab Toxicol. 2008;4(6):771–82.
https://doi.org/10.1517/17425255.4.6.771
.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献